文献速递质量管理与危急值

基于质量指标的风险管理持续改进公共卫生实验室分析前过程

Continual improvement of the pre-analytical process in a public health laboratory with quality indicators-based risk management.
PubMed 文献 · Clin Chem Lab Med · 2019-01-01

本研究在Kayseri公共卫生实验室(KPHL)以分析前质量指标(QI)结合失效模式与效应分析(FMEA)进行风险评估,比较QI百分比与IFCC性能规范、风险优先数(RPN)与风险等级量表,并对需纠正的QI实施风险处置后重新评估。结果显示4项QI的RPN需纠正,风险处置后「转录错误」的性能与风险等级、「样本识别错误」和「样本储存不当」的风险等级及「溶血样本」的性能均获持续改进;「样本储存不当」风险评分最高,源于外围采样单元的储存与离心问题。

要点

  • 基于QI的FMEA风险管理可降低分析前风险等级并提升QI性能。
  • 4项分析前QI的RPN按风险评价量表需采取纠正措施。
  • 外围采样单元的样本储存与离心问题导致「样本储存不当」风险最高。

核心结论

  • 基于预设质量指标的风险管理可降低分析前过程的风险等级并提升QI性能,为持续改进提供循证示例。

研究设计与样本

  • 在服务家庭医生并从中外围采样单元采集样本的Kayseri公共卫生实验室(KPHL)开展研究。
  • 采用失效模式与效应分析(FMEA)对分析前质量指标进行风险评估,量化QI百分比与风险优先数(RPN)。

主要发现

  • 4项QI相关的RPN按风险评价量表需要纠正措施。
  • 风险处置后,「转录错误」的性能与风险等级获得持续改进。
  • 风险处置后,「样本识别错误」和「样本储存不当」的风险等级获得改进。
  • 风险处置后,「溶血样本」的性能获得改进。
  • 「样本储存不当」风险评分最高,归因于不属于KPHL责任的外围采样单元样本储存与离心问题。

关键数值与推荐

  • QI百分比与IFCC性能规范比较,RPN与风险等级量表比较,必要时制定纠正措施。
  • 风险处置效果以新的QI百分比和预设QI的RPN重新评估。

临床怎么用

  • 公共卫生实验室分析前过程的风险优先级可能不同,应结合本地QI数据设定风险管理重点。
  • 对RPN超风险量表的QI实施纠正措施后,应以QI百分比与RPN复评以验证持续改进。

局限性

  • 「样本储存不当」最高风险源于不属于KPHL责任的外围采样单元储存与离心问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Quality indicators (QIs) and risk management are important tools for a quality management system designed to reduce errors in a laboratory. This study aimed to show the effectiveness of QI-based risk management for the continual improvement of pre-analytical processes in the Kayseri Public Health Laboratory (KPHL) which serves family physicians and collects samples from peripheral sampling units. Methods QIs of pre-analytical process were used for risk assessment with the failure modes and effects analysis (FMEA) method. Percentages and risk priority numbers (RPNs) of QIs were quantified. QI percentages were compared to the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) performance specifications and RPNs were compared to risk level scale, and corrective actions planned if needed. The effectiveness of risk treatment actions was re-evaluated with the new percentages and with RPNs of predefined QIs. Results RPNs related to four QIs required corrective action according to the risk evaluation scale. After risk treatment, the continual improvement was achieved for performance and risk level of "transcription errors", for risk levels of "misidentified samples" and "not properly stored samples" and for the performance of "hemolyzed samples". "Not properly stored samples" had the highest risk score because of sample storage and centrifugation problems of peripheral sampling units which are not under the responsibility of the KPHL. Conclusions Public health laboratories may have different risk priorities for pre-analytical process. Risk management based on predefined QIs can decrease the risk levels and increase QI performance as evidence-based examples for continual improvement of the pre-analytical process.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Karadağ C, Demirel NN. Continual improvement of the pre-analytical process in a public health laboratory with quality indicators-based risk management. Clin Chem Lab Med. 2019. PMID: 31050651. doi:10.1515/cclm-2019-0019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。